Clinical Trials in Salt Lake City

Showing 9121-9140 of 16,694 trials

CD24Fc With Ipilimumab and Nivolumab to Decrease irAE (CINDI)

NCT04060407

This is a phase Ib/II clinical trial to test safety and efficacy of combining CD24Fc with ipilimumab and nivolumab to decrease irAE, with built-in interim analyses, and safety and response stopping rules.

Metastatic Melanoma

Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Started Jun 2021

Salt Lake City, Utah, United States

COMPLETEDPhase 2< 1 mile

Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy

NCT01020968

This study is designed to assess the safety profile and the efficacy of cardiac repair cells (CRCs) administered via catheter in treating patients with dilated cardiomyopathy (DCM).

Dilated Cardiomyopathy

Vericel Corporation22 participantsStarted Dec 2009

Minneapolis, Minnesota, United States • Cleveland, Ohio, United States • Salt Lake City, Utah, United States

COMPLETEDPhase 2/3< 1 mile

Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

NCT02785939

This phase II/III trial studies how well palbociclib works in treating cell cycle gene alteration positive patients with stage IV squamous cell lung cancer that has come back after previous treatment. This is a sub-study that includes all screened patients positive for cell cycle gene alterations which can cause tumor cells to grow more quickly. Palbociclib may slow cell cycle progression and may be able to shrink tumors.

CCND1 Gene AmplificationCCND2 Gene AmplificationCCND3 Gene Amplification+3 more

SWOG Cancer Research Network53 participantsStarted Sep 2014

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +1062 more locations

CD24Fc With Ipilimumab and Nivolumab to Decrease irAE (CINDI)

Use of Ixmyelocel-T (Formerly Catheter-based Cardiac Repair Cell [CRC]) Treatment in Patients With Heart Failure Due to Dilated Cardiomyopathy

Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

Find Trials by Condition in Salt Lake City

Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

BAX 855 PK-guided Dosing

Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension)

Loteprednol vs. Prednisolone and Fluorometholone

Registry of Sustained Immunity to COVID-19 Among ESKD Patients

The BEACON Study (Breast Cancer Outcomes With NKTR-102)

Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy

A Novel Approach to Infantile Spasms

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy

Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)

Open Label Study of Subcutaneous Immunoglobulin (SCIg) in Myasthenia Gravis

MAGNOLIA: Extension Study of Patients With Non-infectious Uveitis Who Participated in CLS1001-301

Safety and Efficacy Study of Autologous Concentrated Bone Marrow Aspirate (cBMA) for Critical Limb Ischemia (CLI)

Bupivacaine Effectiveness and Safety in SABER® Trial

DEXYCU (Dexamethasone Intraocular Suspension) 9% Retrospective Study 001